一种来自Bothrops cotiara毒素的新型金属蛋白酶衍生的密抑制了血管酶转化酶活性
Jackson Gabriel Miyamoto1, Eduardo Shigueo Kitano2, André Zelanis3
1Department of Biochemistry, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Biochimie
|October 15, 2023
概括
研究人员发现了一种新的蛇毒,Bc-7a,来自Bothrops cotiara. 这种强烈抑制血管酶转化酶 (ACE),为新的高血压药物提供潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 蛇毒含有针对特定分子的蛋白质和.
- 识别这些毒素可以从天然基架上发现新药.
研究的目的:
- 在Bothrops cotiara毒中识别新型.
- 描述一个新发现的的血管酶转化酶 (ACE) 抑制活性.
主要方法:
- 基于质谱的基组学被用来测序.
- 使用光共振能量转移 (FRET) 基质试验来确定ACE抑制.
主要成果:
- 从Bothrops cotiara毒液中发现了一种新型的7-残留,Bc-7a.
- Bc-7a表现出强烈的抑制两种 angiotensin转化酶 (ACE) 的领域与Ki <1μM.
- 该的特点是N端的酸和C端的PFR基因,同类于布拉迪基宁.
结论:
- 一种新的蛇毒,BC-7a,具有显著的 ACE 抑制活性.
- 这一发现扩大了从蛇毒中获取的已知的ACE抑制的范围.
- Bc-7a可能有助于在中毒中观察到的低血压效应,并有可能用于药物开发.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
677
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
677
Antihypertensive Drugs: Direct Renin Inhibitors
652
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
652
Antihypertensive Drugs: Angiotensin II Receptor Blockers
762
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
762
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
441
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
441
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K


